<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03983941</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00000281</org_study_id>
    <nct_id>NCT03983941</nct_id>
  </id_info>
  <brief_title>IPACK Versus Popliteal Sciatic Nerve Block in ACL Reconstruction</brief_title>
  <official_title>Comparison of Postoperative Analgesic Efficacy of Adductor Canal Block With IPACK Versus Adductor Canal and Popliteal Sciatic Nerve Block in Patients Undergoing Arthroscopic Anterior Cruciate Ligament Reconstruction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sujana Dontukurthy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nationwide Children's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective study comparing femoral nerve block plus sciatic nerve block to femoral
      nerve block plus infiltration of the posterior knee capsule (IPACK) in patients undergoing
      arthroscopic anterior cruciate ligament reconstruction. Femoral nerve block via the adductor
      canal (FNB-AC) with IPACK may provide effective analgesia while avoiding the motor block
      involved with sciatic nerve block. The lack of motor block is important to facilitate
      postoperative ambulation and physical therapy.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">August 30, 2019</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post-operative pain scores</measure>
    <time_frame>Immediately post-operatively and up to 48 hours post-discharge, an average of 48 hours</time_frame>
    <description>Visual Analogue Scale (VAS) pain scores (0 being no pain and 10 being worst pain) from arrival to post-anesthesia care unit (PACU) to 48 hours after discharge from surgery center.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intra-operative and post-operative opioid consumption</measure>
    <time_frame>Intra-operative and up to 48 hours post-discharge, an average of 48 hours</time_frame>
    <description>Number of doses of narcotic pain medicine administered during surgery and up to 48 hours after discharge from surgery center.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Anterior Cruciate Ligament Tear</condition>
  <arm_group>
    <arm_group_label>FNB-AC + Sciatic nerve block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive up to 20 mL of 0.2% ropivacaine for FNB-AC and up to 20 mL of 0.2% ropivacaine for sciatic nerve block under ultrasound guidance.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>FNB-AC + IPACK</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive up to 20 mL of 0.2% ropivacaine for FNB-AC and up to 20 mL of 0.2% ropivacaine for posterior knee capsular infiltration under ultrasound guidance (IPACK)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine injection</intervention_name>
    <description>Total dose not to exceed 3 mg/kg of ropivacaine.</description>
    <arm_group_label>FNB-AC + IPACK</arm_group_label>
    <arm_group_label>FNB-AC + Sciatic nerve block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients less than 21 years of age

          -  American Society of Anesthesiologists physical status I and II

          -  Undergoing elective anterior cruciate ligament reconstruction

        Exclusion Criteria:

          -  They are unable or unwilling to take part in the study

          -  History of allergy to any of the medications administered for the nerve block

          -  Contraindication to peripheral nerve block

          -  Patients who are unable to understand instructions or questions related to the study
             or the families required language interpretation

          -  Patients who consume opioid medications for more than three days per week for more
             than a month prior to surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>21 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Nationwide Children's Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>June 10, 2019</study_first_submitted>
  <study_first_submitted_qc>June 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 12, 2019</study_first_posted>
  <last_update_submitted>October 8, 2019</last_update_submitted>
  <last_update_submitted_qc>October 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 9, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Nationwide Children's Hospital</investigator_affiliation>
    <investigator_full_name>Sujana Dontukurthy</investigator_full_name>
    <investigator_title>Clinical Assistant Professor of Anesthesiology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anterior Cruciate Ligament Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

